CEO and Chairman Ross Jack bought $39,350 worth of shares (14,340 units at $2.74), increasing direct ownership by 4% to 361,207 units (SEC Form 4)
$SNYR
Other Pharmaceuticals
Health Care
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Synergy CHC Corp. [ SNYR ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 02/21/2025 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock, par value $0.00001 per share | 02/21/2025 | P | 300 | A | $4(1)(2) | 347,177 | D | |||
| Common Stock, par value $0.00001 per share | 02/24/2025 | P | 500 | A | $4.07(1)(3) | 347,677 | D | |||
| Common Stock, par value $0.00001 per share | 02/25/2025 | P | 580 | A | $3.77(1)(4) | 348,257 | D | |||
| Common Stock, par value $0.00001 per share | 02/26/2025 | P | 200 | A | $3.78(1)(5) | 348,457 | D | |||
| Common Stock, par value $0.00001 per share | 02/27/2025 | P | 100 | A | $3.94 | 348,557 | D | |||
| Common Stock, par value $0.00001 per share | 03/05/2025 | P | 100 | A | $3.68 | 348,657 | D | |||
| Common Stock, par value $0.00001 per share | 03/07/2025 | P | 200 | A | $3.52(1)(6) | 348,857 | D | |||
| Common Stock, par value $0.00001 per share | 03/10/2025 | P | 100 | A | $3.67 | 348,957 | D | |||
| Common Stock, par value $0.00001 per share | 03/11/2025 | P | 200 | A | $3.64(1)(7) | 349,157 | D | |||
| Common Stock, par value $0.00001 per share | 03/12/2025 | P | 300 | A | $3.38(1)(8) | 349,457 | D | |||
| Common Stock, par value $0.00001 per share | 03/13/2025 | P | 200 | A | $3.52(1)(9) | 349,657 | D | |||
| Common Stock, par value $0.00001 per share | 03/14/2025 | P | 200 | A | $3.59(1)(10) | 349,857 | D | |||
| Common Stock, par value $0.00001 per share | 03/17/2025 | P | 100 | A | $3.66 | 349,957 | D | |||
| Common Stock, par value $0.00001 per share | 03/18/2025 | P | 100 | A | $3.66 | 350,057 | D | |||
| Common Stock, par value $0.00001 per share | 03/19/2025 | P | 100 | A | $3.11 | 350,157 | D | |||
| Common Stock, par value $0.00001 per share | 03/20/2025 | P | 300 | A | $3.52(1)(11) | 350,457 | D | |||
| Common Stock, par value $0.00001 per share | 03/21/2025 | P | 200 | A | $3.19(1)(12) | 350,657 | D | |||
| Common Stock, par value $0.00001 per share | 03/24/2025 | P | 100 | A | $3.24 | 350,757 | D | |||
| Common Stock, par value $0.00001 per share | 03/25/2025 | P | 200 | A | $3.17(1)(13) | 350,957 | D | |||
| Common Stock, par value $0.00001 per share | 03/26/2025 | P | 100 | A | $3.26 | 351,057 | D | |||
| Common Stock, par value $0.00001 per share | 03/27/2025 | P | 100 | A | $3.43 | 351,157 | D | |||
| Common Stock, par value $0.00001 per share | 03/28/2025 | P | 550 | A | $3.07(1)(14) | 351,707 | D | |||
| Common Stock, par value $0.00001 per share | 03/31/2025 | P | 1,300 | A | $2.58(1)(15) | 353,007 | D | |||
| Common Stock, par value $0.00001 per share | 04/02/2025 | P | 200 | A | $2.57(1)(16) | 353,207 | D | |||
| Common Stock, par value $0.00001 per share | 04/03/2025 | P | 900 | A | $2.53(1)(17) | 354,107 | D | |||
| Common Stock, par value $0.00001 per share | 04/04/2025 | P | 5,000 | A | $2.3(1)(18) | 359,107 | D | |||
| Common Stock, par value $0.00001 per share | 04/07/2025 | P | 1,110 | A | $2.25(1)(19) | 360,207 | D | |||
| Common Stock, par value $0.00001 per share | 04/08/2025 | P | 200 | A | $2.23(1)(20) | 360,407 | D | |||
| Common Stock, par value $0.00001 per share | 04/09/2025 | P | 500 | A | $2(1)(21) | 360,907 | D | |||
| Common Stock, par value $0.00001 per share | 04/10/2025 | P | 300 | A | $1.78(1)(22) | 361,207 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Explanation of Responses: |
| 1. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (22) to this Form 4. |
| 2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.863 to $4.085, inclusive. |
| 3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.863 to $4.085, inclusive. |
| 4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.863 to $4.085, inclusive. |
| 5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.863 to $4.085, inclusive. |
| 6. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.451 to $3.590, inclusive. |
| 7. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.625 to $3.656, inclusive. |
| 8. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.324 to $3.404, inclusive. |
| 9. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.464 to $3.567, inclusive. |
| 10. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.585 to $3.593, inclusive. |
| 11. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.366 to $3.651, inclusive. |
| 12. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.169 to $3.216, inclusive. |
| 13. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.140 to $3.200, inclusive. |
| 14. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.987 to $2.160, inclusive. |
| 15. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.155 to $2.894, inclusive. |
| 16. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.516 to $2.617, inclusive. |
| 17. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.395 to $2.643, inclusive. |
| 18. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.170 to $2.430, inclusive. |
| 19. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.000 to $2.358, inclusive. |
| 20. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.231 to $2.235, inclusive. |
| 21. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.908 to $2.055, inclusive. |
| 22. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.765 to $1.790, inclusive. |
| /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact | 05/21/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||